Quantification of serotonin transporters in nonhuman primates using [(123)I]ADAM and SPECT.

UNLABELLED We reported recently a highly selective radioligand, 2-([2-([dimethylamino]methyl)phenyl]thio)-5-[(123)I]iodophenylamine (ADAM), for SPECT imaging of serotonin transporters (SERT). In this article we describe the kinetic modeling of [(123)I]ADAM and its ability to quantitatively and reproducibly measure the concentrations of SERT in the nonhuman primate brain. We also investigate simplified models of tracer behavior that do not require invasive arterial blood sampling. METHODS Three female baboons each underwent 3 [(123)I]ADAM SPECT studies. The studies consisted of a dynamic sequence of seventy-two 5-min scans after injection of 330 +/- 50 MBq (mean +/- SD) [(123)I]ADAM. Rapid arterial blood samples were obtained and corrected for the presence of labeled metabolites. Dynamic imaging and metabolite-corrected plasma data were analyzed using graphic analysis to give the distribution volumes (DVs) of different brain regions. DV ratios (DVRs) of target to cerebellum were derived and compared against a kinetic reference tissue model and simple target-to-background ratio. RESULTS Averaged over all 9 scans, the mean DV in the midbrain was 4.86 +/- 1.06 mL/mL and the mean DV in the cerebellum was 2.25 +/- 0.48 mL/mL. The mean test-retest repeatability of the midbrain DV was 14.5%. The reference tissue model gave a mean midbrain DVR of 2.01 +/- 0.17 and correlated strongly with the DVR calculated from the full kinetic model (correlation coefficient [R(2)] = 0.94; P < 0.001), but with much improved repeatability (test-retest, 5.4%; intersubject variability, 5.2%). Similarly, the simple ratio method gave strong correlations with the full kinetic model (R(2) = 0.89; P < 0.001) and a test-retest of 7.6%. CONCLUSION Accurate, repeatable quantification of SERT in the nonhuman primate brain is possible using kinetic modeling of dynamic [(123)I]ADAM SPECT scans. Simplified models, which do not require arterial blood sampling, gave accurate results that correlated strongly with the full kinetic model. The test-retest reliability of the simplified reference region models was excellent. Quantification of SERT is possible using full kinetic modeling and also with simpler reference region methods.

[1]  S. Kushner,et al.  Simplified reference region model for the kinetic analysis of [99mTc]TRODAT-1 binding to dopamine transporters in nonhuman primates using single-photon emission tomography , 1999, European Journal of Nuclear Medicine.

[2]  L. Farde,et al.  Kinetic Analysis of Central [11C]Raclopride Binding to D2-Dopamine Receptors Studied by PET—A Comparison to the Equilibrium Analysis , 1989, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[3]  P. Acton,et al.  Simplified quantification of dopamine transporters in humans using [99mTc]TRODAT-1 and single-photon emission tomography , 2000, European Journal of Nuclear Medicine.

[4]  David J. Schlyer,et al.  Graphical Analysis of Reversible Radioligand Binding from Time—Activity Measurements Applied to [N-11C-Methyl]-(−)-Cocaine PET Studies in Human Subjects , 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[5]  N. Volkow,et al.  Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[6]  F. Vaccarino,et al.  Eating disorder and obsessive-compulsive disorder: neurochemical and phenomenological commonalities. , 1996, Journal of psychiatry & neuroscience : JPN.

[7]  J. Palacios,et al.  Autoradiography of antidepressant binding sites in the human brain: localization using [3h]imipramine and [3h]paroxetine , 1988, Neuroscience.

[8]  L. Cohen Rational Drug Use in the Treatment of Depression , 1997, Pharmacotherapy.

[9]  H. Kung,et al.  Single-photon emission tomography imaging of serotonin transporters in the non-human primate brain with the selective radioligand [123I]IDAM , 1999, European Journal of Nuclear Medicine.

[10]  G. Sedvall,et al.  Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. , 1986, Science.

[11]  T. Brewerton,et al.  Eating disorders and depression: Is there a serotonin connection? , 1990, Biological Psychiatry.

[12]  C S Patlak,et al.  Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[13]  A. Lammertsma,et al.  Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.

[14]  H. Meltzer Role of Serotonin in Depression a , 1990, Annals of the New York Academy of Sciences.

[15]  P. Acton,et al.  Selective in vitro and in vivo binding of [125I]ADAM to serotonin transporters in rat brain , 2000, Synapse.

[16]  H. Kung,et al.  Noninvasive quantification of dopamine D2 receptors with iodine-123-IBF SPECT. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  J. Mann,et al.  The role of in vivo neurotransmitter system imaging studies in understanding major depression. , 1998, Biological psychiatry.

[18]  Mann Jj The role of in vivo neurotransmitter system imaging studies in understanding major depression. , 1998 .

[19]  Robert B Innis,et al.  Imaging of the serotonergic system: interactions of neuroanatomical and functional abnormalities of depression , 1998, Biological Psychiatry.

[20]  P. Acton,et al.  Single-photon emission tomography imaging of serotonin transporters in the non-human primate brain with the selective radioligand [(123)I]IDAM. , 1999, European journal of nuclear medicine.

[21]  P. Acton,et al.  A novel serotonin transporter ligand: (5-iodo-2-(2-dimethylaminomethylphenoxy)-benzyl alcohol. , 2000, Nuclear medicine and biology.

[22]  P. Acton,et al.  A new single-photon emission computed tomography imaging agent for serotonin transporters: [123I]IDAM, 5-iodo-2-((2-((dimethylamino)methyl)phenyl)thio)benzyl alcohol. , 1999 .

[23]  D J Brooks,et al.  Comparison of Methods for Analysis of Clinical [11C]Raclopride Studies , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[24]  D. Riche,et al.  Anatomical atlas of the baboon's brain in the orbito-meatal plane used in experimental positron emission tomography , 1988, Brain Research Bulletin.

[25]  Y. Agid,et al.  Distribution of Specific High‐Affinity Binding Sites for [3H]Imipramine in Human Brain , 1981, Journal of neurochemistry.

[26]  P. Acton,et al.  Single-photon emission tomography imaging of serotonin transporters in the nonhuman primate brain with [123I]ODAM , 1999, European Journal of Nuclear Medicine.

[27]  D. Kupfer,et al.  Serotonin in Aging, Late-Life Depression, and Alzheimer's Disease: The Emerging Role of Functional Imaging , 1998, Neuropsychopharmacology.

[28]  P. Acton,et al.  Characterization of [123I]IDAM as a novel single-photon emission tomography tracer for serotonin transporters , 1999, European Journal of Nuclear Medicine.

[29]  P. Acton,et al.  2-((2-((dimethylamino)methyl)phenyl)thio)-5-iodophenylamine (ADAM): an improved serotonin transporter ligand. , 2000, Nuclear medicine and biology.